Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4

By  

Current Drug Metabolism, Vol. 9, Iss. 4, 2008-01 ,pp. : 310-322

Bentham Science Publishers

Access to resources Recommend Favorite

Human Cytochromes P450 Associated with the Phase 1 Metabolism of Drugs and other Xenobiotics: A Compilation of Substrates and Inhibitors of the CYP1, CYP2 and CYP3 Families

By  

Current Medicinal Chemistry, Vol. 10, Iss. 19, 2003-10 ,pp. : 1955-1972

Bentham Science Publishers

Access to resources Recommend Favorite

Role of human CYP3A and P-glycoprotein on the absorption of drugs

By van de Waterbeemd H.  

European Journal of Pharmaceutical Sciences, Vol. 12, Iss. 1, 2000-11 ,pp. : 1-1

Elsevier

Access to resources Recommend Favorite

Influence of CYP3A5 polymorphism on the pharmacokinetics of psychiatric drugs

By  

Current Drug Metabolism, Vol. 17, Iss. 3, 2016-03 ,pp. : 227-236

Bentham Science Publishers

Access to resources Recommend Favorite

CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin

By Elens Laure   Nieuweboer Annemieke   Clarke Stephen J   Charles Kellie A   de Graan Anne-Joy   Haufroid Vincent   Mathijssen Ron HJ   van Schaik Ron HN  

Pharmacogenomics, Vol. 14, Iss. 2, 2013-01 ,pp. : 137-149

Future Medicine

Access to resources Recommend Favorite